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Background: In female adolescents and young adults, malignancies of the genital tract are the most frequent type
of cancer, closely followed by Hodgkin’s and non-Hodgkin’s lymphomas.
Case Presentation: We report an unusual case of sporadic Burkitt’s lymphoma (BL) presenting with massive
bilateral ovarian infiltration, peritoneal carcinomatosis and diffuse nodular lesions of the stomach and the intestine
mimicking Krukenberg tumor. Diagnostic biopsies were obtained by endoscopy of the upper gastrointestinal tract.
With intensive chemotherapy, complete remission was rapidly achieved, without life-threatening tumor lysis
syndrome.
Conclusion: Besides metastatic gastric adenocarcinoma, BL is an important differential diagnosis in adolescents
presenting with Krukenberg tumor.
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Cancer in adolescents and young adults is 2.7 times more
common than cancer occurring during the first 15 years
of life. In females aged between 15 to 29 years old, malig-
nancies of the genital tract are the most frequent type of
cancer (18%), closely followed by lymphomas (17%) [1].
Hodgkin lymphomas account for two–thirds of those
cases. The remainder of patients present one of the four
subtypes of non-Hodgkin lymphoma (NHL): diffuse large
B-cell lymphoma, Burkitt’s lymphoma (BL), lymphoblastic
lymphoma or anaplastic large cell lymphoma.Case presentation
A 15 year old girl presented to our outpatient clinic with a
one month history of abdominal pain, vomiting, nausea,
early satiety and weight loss of 3 kg. Clinical examination
showed pallor and pitting oedema. No palpable abdominal
mass was detected clinically but ultrasonography revealed
huge bilateral ovarian masses, suggestive of Krukenberg
tumor. Initial laboratory findings showed normocytic, nor-
mochromic anaemia with a haemoglobin of 93 g/L, a
white blood cell count (WBC) of 16.6 x103/mm3, elevated
platelets of 484,000/mm3 (neutrophils, lymphocytes and* Correspondence: andreas.nydegger@chuv.ch
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reproduction in any medium, provided the orblood film were normal). Total serum proteins as well as
albumin were slightly reduced with 43 g/L and 23 g/L re-
spectively, with normal liver and renal function tests.
Serum lactate dehydrogenase (LDH) level was 334 UI/L,
uric acid 334 μmol/l and ferritin 36 μg/l confirming ab-
sence of tumor lysis. Both alpha foeto-protein (AFP) and
beta human chorionic gonadotropin (βHCG) were within
normal range. The abdominal CT and MRI showed bilat-
eral ovarian masses, peritoneal carcinomatosis, ascites and
diffuse and nodular thickening of the gastric and intestinal
wall (Figure 1).
Suspecting obstructive endoluminal masses, an upper
endoscopy was performed and revealed multiple, large
(2 to 3 cm in diameter), raised ulcerated tumors involving
the stomach, as well as multiple similar lesions throughout
the duodenum and jejunum (Figure 2); multiple biopsies
were taken from several lesions for further analysis. Histo-
logical examination showed diffuse wall infiltration by a
medium sized, monotonous, atypical lymphoid cell popu-
lation with scanty basophilic cytoplasm and a characteris-
tic starry-sky pattern. On immunohistochemistry tumor
cells showed positive staining for B-cell-associated anti-
gens (CD 20, CD 10), B cell lymphoma 6 protein (Bcl6),
paired box gene 5(PAX 5), surface IgM and IgD as well as
monoclonal Kappa light chains. They were negative for B
cell leukemia/lymphoma 2(Bcl2) and T-cell marker (CD5).
These morphological and immunophenotypical features
were consistent with Burkitt’s lymphoma, classified astd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Abdominal CT scan with gastric tumor (a) and MRI
showing bilateral ovarian masses (b).
Figure 2 Gastric (a) and jejunal (b) lesions on upper endoscopy.
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encoded small RNA (EBER) in situ hybridisation showed
an 80% consistency with Epstein Barr Virus (EBV). Finally,
the typical reciprocal chromosomal translocation involv-
ing the proto-oncogene c-MYC on chromosome 8 and
the immunoglobulin-gene heavy chain locus on chromo-
somes 14 [t(8;14)] was found in the tumor cells. Bone
marrow aspirate and biopsy, as well as cerebrospinal fluid
(CSF) were normal.
A nasojejunal feeding tube was inserted because of
subtotal intestinal obstruction by a tumoral mass at the
level of the duodenal bulb. The patient was started on
chemotherapy according to POG 9917 protocol, including
dexamethasone, methotrexate, cyclophosphamide, vincris-
tin, cytarabin and doxorubicin; intrathecal cytarabin and
methotrexate were administered as CNS prophylaxis. To
prevent massive tumor lysis syndrome, hyperhydration
and two doses of rasburicase were administered before
and during the first cycle of chemotherapy. Interestingly,
tumor lysis could be easily controlled and a rapid reso-
lution of clinical signs was observed.According to the protocol, chemotherapy was discon-
tinued after 4 months. An upper endoscopy with biop-
sies was performed and confirmed remission with
absence of lesions.
Discussion and conclusion
To the best of our knowledge, this is the first pediatric
report of Burkitt’s lymphoma mimicking Krukenberg
tumor with synchronous involvement of stomach and
ovary, even though ovarian or gastric implants of Bur-
kitt´s lymphoma are a common finding. Similar reports
have only been described in adult female patients, where
gastric adenocarcinoma was the underlying disease [2,3].
Krukenberg tumor is generally defined as an ovarian
carcinoma that contains a significant component of
mucin-filled signet-ring cells typically lying within a cel-
lular stroma derived from the ovarian stroma. It refers
to a malignancy with metastasis to other organs, classic-
ally the gastrointestinal tract. Today, almost all Kruken-
berg tumors are thought to be metastatic signet-ring cell
carcinoma in the ovary of gastric origin, although rare
examples have been interpreted as primary.
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olds in Europe and the USA. In the 15–19 year-old group,
diffuse large B-cell Lymphomas account for the largest
proportion of NHL cases (37%) followed by BL (21%) [4].
Patients with gastrointestinal BL may present with ab-
dominal pain or distension, gastrointestinal bleeding or
intestinal obstruction resulting from direct compression
of the lumen by an expanding mass or by an intussuscep-
tion triggered by the intraluminal projection of the tumor
mass [5-7]. These acute abdominal symptoms often lead
to emergency laparotomies before a diagnosis of Burkitt’s
lymphoma can be made [8].
Spontaneous intestinal perforation is an uncommon
complication of BL, even though previously reported in
children [9]. Possible explanations for spontaneous
gastrointestinal perforation are tumor necrosis, immune
suppression and protein malnutrition [9,10]. Tumor ne-
crosis is probably the most likely reason as perforation
usually occurs during or after the first cycle of intensive
chemotherapy. Epigastric pain is the first and most com-
mon symptom of gastric perforation. A high degree of
suspicion should be present at all times, as early diagno-
sis and emergency surgery are crucial in saving life in
the setting of such a complication [11].
Burkitt’s and B-cell lymphomas in childhood have an
excellent overall prognosis regardless of the location (ex-
cept for primary central nervous system lymphoma), es-
pecially when treated with contemporary chemotherapy
protocols [12].
Burkitt lymphoma has to be considered as differential
diagnosis in adolescent girls presenting with apparent
Krukenberg tumors. Prognosis remains excellent with
precise histological and molecular diagnosis, early treat-
ment and careful monitoring and prevention of tumor
lysis.
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